ATOS

NASDAQStock

Atossa Therapeutics, Inc.

$5.05+0.00 (+0.00%)

52-Week Range

$3.94

$17.70

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.49

Volume

101.5K

Avg Volume

91.4K

Performance

+20.24%

-52.89%

-59.04%

YTD

-46.61%

-53.89%

-50.50%

-87.62%

Price Chart

ETF Exposure

ATOS is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.00%	1,296,305	$732K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	189	$144	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	6,748	$5K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	32	$24	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	3,842,060	$2.2M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	20,208	$15K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,742	$1K	$1.29B	0.17%

About ATOS ETF Exposure

Atossa Therapeutics, Inc. (ATOS) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $5.05. Investors can gain exposure to ATOS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ATOS, sorted by portfolio weight.